Anxiolytic drug discovery: what are the novel approaches and how can we improve them?

Author： Stewart Adam Michael Kalueff Allan V

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.1, 2014-01, pp. : 15-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How can we enable drug discovery informatics for personalized healthcare?

By Scheiber Josef

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 219-224

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to flavivirus drug discovery

By Botting Carolyn Kuhn Richard J

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 417-428

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to anticonvulsant drug discovery

By Miziak Barbara Chrościńska-Krawczyk Magdalena Błaszczyk Barbara Radzik Iwona Czuczwar Stanisław J

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1415-1427

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches in antimalarial drug discovery

By Held Jana Kreidenweiss Andrea Mordmüller Benjamin

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1325-1337

Informa Healthcare

Access to resources Recommend Favorite

Novel Approaches to Antimalarial Drug Discovery

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 2, 2006-06 ,pp. : 173-204

Bentham Science Publishers

Access to resources Recommend Favorite